New Delhi, December 24, 2019: Roche Diabetes Care (RDC) India today announced that its Accu-Chek brand of blood glucose motoring products are compliant with the revised standards of IS/ISO 15197:2013 announced by Central Drugs Standard Control Organisation (CDSCO), Directorate General of Health Services, Ministry of Health & Family Welfare.
The original notification issued on 16 February 2016 stated that the revised IS/ISO 15197:2013 were to be effective after 36 months of its publication by Bureau of Indian Standards (BIS), which was stated to be October, 19, 2016. Given the 36-month period of transition the effective date for the implementation of IS/ISO 15197:2013 is now 18 October 2019.
Using products that comply with the above mentioned standards will give confidence to people with diabetes that their meter gives most accurate readings of their blood glucose level, thereby enabling better management of their condition.
Corporate Comm India(CCI Newswire)
Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…
- This specialized division empowers patients with neurological disorders to reclaim their mobility through a…
SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…
Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…
DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…
Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…